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To the Editor,
We appreciate the positive comments of Dr Stella and Dr
Wykrzykowska [1] on our paper on bifurcation stenting in
the Catharina Hospital, Eindhoven [2] and would like to
react as follows:
1. RCT versus our retrospective analysis.
We agree that an RCT cannot be compared with a ret-
rospective analysis. However, we do not agree on the note
of natural selection bias. On the contrary, we believe that
our analysis is completely unbiased because literally all
patients admitted for bifurcation stenting in the year 2013
were included.
In a randomised controlled trial with strict inclusion and
exclusion criteria, the population is more selected.
2. Baseline characteristics.
The baseline characteristics as presented in Table 1 of
our paper refer to patient characteristics. The angiographic
characteristics are mentioned separately and of course these
are different between the two groups. That is also what we
emphasise in our paper and in the discussion we suggest that
the angiographic complexity might be one of the reasons
to grade up from a provisional stent strategy to a more
complex stent strategy.
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3. Medina classification.
We choose for the Medina classification because this
is the most commonly used classification and most well-
known to general interventionalists.
4. Clinical restenosis rates.
We do not agree that the MACE rates at one year are
relatively high. As presented in Table 3 of our paper, the
mortality was 5.5% and 7.3% in the two groups at one year.
Thanks to the ‘Meetbaar Beter’ project, which is a joint
registry for all Dutch heart centres, [3] we know that in
patients with a comparable age the 1-year mortality for all
PCIs in that age group for all Dutch heart centres with
surgical back-up (including Maastricht UMC and AMC
Amsterdam) ranges from 4 to 7%. Therefore, when tak-
ing into account that bifurcation stenting will be at least
not less complex than the average PCI and considering that
in 44 patients an LM/LAD/LCX bifurcation was present,
these mortality data are exactly in line with the averages of
all Dutch heart centres. A similar note can be made for MI
rates and TVR rates.
This does not take away the fact that a bifurcation PCI is
a ‘different animal’ as stated by Stella and Wykrzykowska.
And we agree completely about what they call the KISS
approach (keep it safe and simple). That was the bottom
line of our paper and our message would be: ‘Start simple,
grade up if mandatory’.
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